You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.

Xpert Xpress SARS-CoV-2 Test
Home / Tests / Healthcare Associated Infections / Xpert MRSA NxG

Xpert® MRSA NxG

Active MRSA surveillance testing in about an hour

Ordering Info

The Need


Control of MRSA in healthcare settings requires rapid and accurate tests to detect colonized patients.

  • Approximately 171,200 healthcare-associated MRSA infections are acquired annually in the European Union (EU), resulting in 5,400 attributable deaths, more than 1 million excess days of hospitalization and € 380 million in excess in-hospital costs1
  • Between 2 and 53 million people are estimated to carry MRSA worldwide2
  • The average length of stay (LOS) for all MRSA patients in the EU is 11.5 days with an average attributable cost of €7,478 per patient3

The Solution


Xpert® MRSA NxG is an accurate, rapid, on-demand PCR test that will help to:

  • Optimize the effectiveness of your infection control program and guide the judicious use of barrier precautions
  • Guide decolonization practices that reduce infection rates and decrease MRSA transmission
  • Help decrease LOS and improve patient and bed management
  • Help reduce infection control costs by limiting unnecessary use of isolation rooms and improve clinical outcomes
  • Detect the presence of MRSA by targeting both the orfXSCCmec junction and the mecA or mecC genes for a more accurate MRSA detection
  • Improve antibiotic stewardship by avoiding unnecessary

The Impact


Xpert MRSA NxG is an accurate, rapid, on-demand PCR test that provides actionable results in about an hour: Shift your lab from reactive to proactive

  • Rapidly identify MRSA colonized patients that require contact precautions to reduce the risk of transmission and avoid costly outbreaks
  • Improve overall patient safety by reducing the risk of MRSA infection
  • According to a published German study, implementation of a rapid MRSA screening surveillance program can achieve the following results4
  • Decreased infection rate 50%
  • Reduced cost 58%
  • Total hospital savings € 408,894 in average per year

(1) Köck R et al., Euro Surveill 2014 July
(2) Grundmann H, et al. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet. 2006 Sep 2;368(9538):874-85.
(3) Macedo - vinas et al. Journal of Hospital Infection 84 (2013) 132-137
(4) Walter M, et al. Investment in Rapid on Demand Screening for MRSA and Immediate Isolation of MRSA Positive Patients Reduces Overall Hospital Costs in a German Emergency Hospital. Poster presentated at EAHM 2013 Nov 28-29. Luxembourg

Ordering Info


Xpert® MRSA NxG

Number of Tests: 120

Catalog #: GXMRSA-NXG-CE-120

Xpert® MRSA NxG

Number of Tests: 10

Catalog #: GXMRSA-NXG-CE-10

Xpert® MRSA NxG

Number of Swabs: 50

Catalog #: 900-0370

Educational Materials

Back to Top